Jacob C. Cogan
YOU?
Author Swipe
View article: HTRS2025.P2.59 Use of Therapeutic Plasma Exchange to Reduce or Prevent Bleeding Events in Rare Acquired FXIII-Related Bleeding Disorders
HTRS2025.P2.59 Use of Therapeutic Plasma Exchange to Reduce or Prevent Bleeding Events in Rare Acquired FXIII-Related Bleeding Disorders Open
View article: HTRS2025.P1.44 Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions
HTRS2025.P1.44 Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions Open
View article: ‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation
‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation Open
View article: Uncertainty-Aware Large Language Models for Explainable Disease Diagnosis
Uncertainty-Aware Large Language Models for Explainable Disease Diagnosis Open
Explainable disease diagnosis, which leverages patient information (e.g., signs and symptoms) and computational models to generate probable diagnoses and reasonings, offers clear clinical values. However, when clinical notes encompass insu…
View article: 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions Open
View article: Identifying and addressing underuse in hematologic care through systems-based hematology
Identifying and addressing underuse in hematologic care through systems-based hematology Open
View article: Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysisImpact of B-cell malignancy therapy on COVID-19 outcomes
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysisImpact of B-cell malignancy therapy on COVID-19 outcomes Open
Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe…
View article: Iron deficiency resolution and time to resolution in an American health system
Iron deficiency resolution and time to resolution in an American health system Open
Iron deficiency (ID) is a global health problem with consequences independent of anemia, including impaired cognition and exercise tolerance. The time from laboratory diagnosis to resolution of ID has not been defined. In a retrospective r…
View article: Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review
Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review Open
View article: Data from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Data from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 Open
Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe…
View article: Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 Open
Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
View article: Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 Open
Supplementary Figure from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
View article: Data from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
Data from Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19 Open
Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe…
View article: New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer Open
Background Sedative-hypnotic medications are used to treat chemotherapy-related nausea, anxiety, and insomnia. However, prolonged sedative-hypnotic use can lead to dependence, misuse, and increased health-care use. We aimed to estimate the…
View article: New persistent opioid use among adolescents and young adults with sarcoma
New persistent opioid use among adolescents and young adults with sarcoma Open
Background Adolescents and young adults (AYA) with sarcoma experience both acute and chronic pain related to their disease and treatment. Studies in older adults have reported a high risk of persistent opioid use after cancer therapy among…
View article: Neutrophil-erythrocyte rosettes suggestive of Coombs-negative autoimmune haemolysis
Neutrophil-erythrocyte rosettes suggestive of Coombs-negative autoimmune haemolysis Open
View article: Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use
Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use Open
In this study, a relatively small percentage of surgical patients were prescribed benzodiazepines in the perioperative period; however, 1 in 5 of these patients went on to persistent benzodiazepine use.
View article: New and Persistent Controlled Substance Use Among Patients Undergoing Mastectomy and Reconstructive Surgery
New and Persistent Controlled Substance Use Among Patients Undergoing Mastectomy and Reconstructive Surgery Open
Purpose Prolonged use of controlled substances can place patients at increased risk of dependence and complications. Women who have mastectomy and reconstructive surgery (M+R) may be vulnerable to becoming new persistent users (NPUs) of op…
View article: Unique Therapeutic Approaches for Targeting Epigenetic Machinery in T-cell Lymphoma
Unique Therapeutic Approaches for Targeting Epigenetic Machinery in T-cell Lymphoma Open
Growing knowledge on T-cell lymphoma (TCL) biology has led to the understanding that TCLs harbor derangements in proteins modulating epigenetic control. Some such derangements include mutations in TET2, IDH2, DNMT3A, EP300, and CBP. In add…